No7 Protect And Perfect Intense Advanced Day Cream Spf 30
Avobenzone,octisalate, Octocrylene
Bcm Ltd
Human Otc Drug
NDC 11489-101No7 Protect And Perfect Intense Advanced Day Cream Spf 30 also known as Avobenzone,octisalate, Octocrylene is a human otc drug labeled by 'Bcm Ltd'. National Drug Code (NDC) number for No7 Protect And Perfect Intense Advanced Day Cream Spf 30 is 11489-101. This drug is available in dosage form of Cream. The names of the active, medicinal ingredients in No7 Protect And Perfect Intense Advanced Day Cream Spf 30 drug includes Avobenzone - 1.5 g/50g Octisalate - 2.5 g/50g Octocrylene - 3.75 g/50g . The currest status of No7 Protect And Perfect Intense Advanced Day Cream Spf 30 drug is Active.
Drug Information:
| Drug NDC: | 11489-101 |
| The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC. |
| Proprietary Name: | No7 Protect And Perfect Intense Advanced Day Cream Spf 30 |
| Also known as the trade name. It is the name of the product chosen by the labeler. |
| Product Type: | Human Otc Drug |
| Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing. |
| Non Proprietary Name: | Avobenzone,octisalate, Octocrylene |
| Also known as the generic name, this is usually the active ingredient(s) of the product. |
| Labeler Name: | Bcm Ltd |
| Name of Company corresponding to the labeler code segment of the ProductNDC. |
| Dosage Form: | Cream |
| The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources. |
| Status: | Active |
| FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved. |
| Substance Name: | AVOBENZONE - 1.5 g/50g
OCTISALATE - 2.5 g/50g
OCTOCRYLENE - 3.75 g/50g
|
| This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted. |
| Route Details: | TOPICAL
|
| The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
Marketing Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Marketing Category: | OTC MONOGRAPH NOT FINAL |
| Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
| Marketing Start Date: | 30 Jun, 2016 |
| This is the date that the labeler indicates was the start of its marketing of the drug product. |
| Marketing End Date: | 22 Dec, 2025 |
| This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached. |
| Application Number: | part352 |
| This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null. |
| Listing Expiration Date: | 31 Dec, 2023 |
| This is the date when the listing record will expire if not updated or certified by the firm. |
OpenFDA Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Manufacturer Name: | BCM Ltd
|
| Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC. |
| Original Packager: | Yes
|
| Whether or not the drug has been repackaged for distribution. |
| UNII: | G63QQF2NOX
4X49Y0596W
5A68WGF6WM
|
| Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information. |
Packaging Information:
| Package NDC | Description | Marketing Start Date | Marketing End Date | Sample Available |
|---|
| 11489-101-01 | 1 JAR in 1 CARTON (11489-101-01) / 50 g in 1 JAR | 22 Sep, 2016 | N/A | No |
| Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together. |
Purpose:
Uses uses - helps prevent sunburn
Product Elements:
No7 protect and perfect intense advanced day cream spf 30 avobenzone,octisalate, octocrylene avobenzone avobenzone octocrylene octocrylene octisalate octisalate water glycerin dimethicone cetearyl glucoside aluminum starch octenylsuccinate tribehenin potassium cetyl phosphate ammonium acryloyldimethyltaurate/vp copolymer phenoxyethanol shea butter butylene glycol methylparaben dimethiconol (40 cst) propylene glycol dipropylene glycol xanthan gum ethylparaben vitamin a palmitate sodium ascorbyl glucoside medicago sativa leaf edetate sodium tert-butyl alcohol polysorbate 20 carbomer 940 dimethylmethoxy chromanol potassium hydroxide ethylhexylglycerin panax ginseng root oil tocopherol hydroxyethyl cellulose (100 mpa.s at 2%) morus alba leaf silicon palmitoyl tetrapeptide-7 sodium benzoate palmitoyl tripeptide-1
Indications and Usage:
Directions directions apply liberally 15 minutes before sun exposure reapply at least every 2 hours use a water resistant sunscreen if swimming or sweating children under 6 months of age: ask a doctor sun protection measures. spending time in the sun increases your risk of skin cancer and early skin aging. to decrease this risk, regularly use a sunscreen with a broad spectrum spf value of 15 or higher and other sun protection measures including: limit time in the sun, especially from 10 a.m - 2 p.m. wear long-sleeved shirts,pants,hats and sunglasses.
Warnings and Cautions:
Warnings for external use only do not use on damaged or broken skin when using this product keep out of eyes. rinse with water to remove.
Description:
Description visibly younger discover no7's acclaimed protect and perfect intense advanced skincare, enhanced with our even more powerful day and night creams to give younger looking skin in 2 weeks. powerd by matrixyl 3000 plus tm, a next generation peptide that works to restore more youthful skin. with our unique double defence technology - a powerful blend of antioxidants - it helps to protect skin from future signs of ageing, keeping it looking younger for longer. after 2 weeks skin looks younger, by 4 weeks deep lines and wrinkles are visibly reduced. formulated by no7, leaders in anti-ageing skincare science. serum supercharge your skincare routine with this clinically proven serum. when asked, 80% of women said this serum provided the best anti-ageing results they had ever seen. independently tested and proven to work, with results that keep getting better with continued use. no7 serums are designed to be used underneath your moisturiser to deliver key actives into the skin. day cream formulated with the protective power of sunscreen broad spectrum spf 30 to give your skin protection from the no1 cause of visible skin ageing. during the day, double defence technology protects skin and boosts natural defences against environmental stress. supercharged by matrixyl 3000 plus tm, it is the perfect partner to our protect and perfect intense advanced serum. they have been formulated to be used together to deliver even better anti-ageing results. night cream created to work in harmony with your skin's natural night time repair processes to help your skin recover from the day. double defence technology gives no7's most advanced night-time protction against the damaging effects of free radicals generated from the sun and environmental stress during the day. supercharged by matrixyl 3000 plus tm, it is the perfect night-time partner to our protect and perfect intense advanced serum. they have been formulated to be used together to deliver even better anti-ageing results. for best results: after cleansing, smooth no7 protect and perfect intense advanced serum onto your face and neck. in the morning, follow with no7 protect and perfect intense advanced day cream. at night, follow with no7 protect and perfect intense advanced night cream.
Information for Patients:
Serum made in germany day and night creams made in the uk the boots company plc nottingham england ng2 3aa dist in the usa by boots retail usa inc. new york ny 10005 www.boots.com/no7
Package Label Principal Display Panel:
Carton no7ppiadvancedantiageingskincarekit.jpg